1. Home
  2. GRCE vs CASI Comparison

GRCE vs CASI Comparison

Compare GRCE & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRCE
  • CASI
  • Stock Information
  • Founded
  • GRCE 2002
  • CASI 1991
  • Country
  • GRCE United States
  • CASI China
  • Employees
  • GRCE N/A
  • CASI N/A
  • Industry
  • GRCE
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRCE
  • CASI Health Care
  • Exchange
  • GRCE NYSE
  • CASI Nasdaq
  • Market Cap
  • GRCE 32.1M
  • CASI 33.4M
  • IPO Year
  • GRCE N/A
  • CASI 1996
  • Fundamental
  • Price
  • GRCE $2.31
  • CASI $2.11
  • Analyst Decision
  • GRCE Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • GRCE 1
  • CASI 1
  • Target Price
  • GRCE $12.00
  • CASI $6.00
  • AVG Volume (30 Days)
  • GRCE 27.2K
  • CASI 8.8K
  • Earning Date
  • GRCE 05-15-2025
  • CASI 03-31-2025
  • Dividend Yield
  • GRCE N/A
  • CASI N/A
  • EPS Growth
  • GRCE N/A
  • CASI N/A
  • EPS
  • GRCE N/A
  • CASI N/A
  • Revenue
  • GRCE N/A
  • CASI $28,537,000.00
  • Revenue This Year
  • GRCE N/A
  • CASI N/A
  • Revenue Next Year
  • GRCE N/A
  • CASI $134.79
  • P/E Ratio
  • GRCE N/A
  • CASI N/A
  • Revenue Growth
  • GRCE N/A
  • CASI N/A
  • 52 Week Low
  • GRCE $2.07
  • CASI $2.04
  • 52 Week High
  • GRCE $4.97
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • GRCE N/A
  • CASI 42.87
  • Support Level
  • GRCE N/A
  • CASI $2.10
  • Resistance Level
  • GRCE N/A
  • CASI $2.52
  • Average True Range (ATR)
  • GRCE 0.00
  • CASI 0.22
  • MACD
  • GRCE 0.00
  • CASI -0.00
  • Stochastic Oscillator
  • GRCE 0.00
  • CASI 14.58

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: